Curoverse Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 15

Employees

  • Latest Deal Type
  • M&A

Curoverse General Information

Description

Provider of genomic and biomedical computing platform intended to empower scientists and clinicians to focus on making breakthrough discoveries and delivering real-world care. The company's genomic and biomedical computing platform enables patient-level genomic and health data to be securely accessible for drug development and precision medicine, enabling scientists and clinicians to manage, process, analyze and share massive biomedical data sets for everything from genomics to imaging.

Contact Information

Formerly Known As
Clinical Future
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 212 Elm Street
  • 3rd Floor
  • Somerville, MA 02144
  • United States
Primary Industry
Business/Productivity Software
Other Industries
Database Software
Vertical(s)
Corporate Office
  • 212 Elm Street
  • 3rd Floor
  • Somerville, MA 02144
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Curoverse Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 03-Aug-2017 Completed Generating Revenue
3. Grant 01-Jan-2017 Completed Generating Revenue
2. Later Stage VC 24-Mar-2015 $1.5M $3.2M Completed Startup
1. Seed Round 18-Feb-2014 $1.7M $1.7M Completed Startup
To view Curoverse’s complete valuation and funding history, request access »

Curoverse Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series Seed
To view Curoverse’s complete cap table history, request access »

Curoverse Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of genomic and biomedical computing platform intended to empower scientists and clinicians to focus on making b
Business/Productivity Software
Somerville, MA
15 As of 2017

San Diego, CA
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Curoverse Competitors (5)

One of Curoverse’s 5 competitors is Verogen, a Formerly PE-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verogen Formerly PE-Backed San Diego, CA
Eagle Genomics Formerly VC-backed London, United Kingdom
AMPED PCR Venture Capital-Backed Aberystwyth, United Kingdom
BC Platforms Private Equity-Backed Zurich, Switzerland
Flatiron Formerly VC-backed New York, NY
You’re viewing 5 of 5 competitors. Get the full list »

Curoverse Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curoverse Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boston Global Ventures Venture Capital Minority
Converge Venture Partners Venture Capital Minority
Hatteras Venture Partners Venture Capital Minority
Hyperplane Venture Capital Venture Capital Minority
MassVentures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Curoverse FAQs

  • When was Curoverse founded?

    Curoverse was founded in 2010.

  • Where is Curoverse headquartered?

    Curoverse is headquartered in Somerville, MA.

  • What is the size of Curoverse?

    Curoverse has 15 total employees.

  • What industry is Curoverse in?

    Curoverse’s primary industry is Business/Productivity Software.

  • Is Curoverse a private or public company?

    Curoverse is a Private company.

  • What is Curoverse’s current revenue?

    The current revenue for Curoverse is .

  • How much funding has Curoverse raised over time?

    Curoverse has raised $3.2M.

  • Who are Curoverse’s investors?

    Boston Global Ventures, Converge Venture Partners, Hatteras Venture Partners, Hyperplane Venture Capital, and MassVentures are 5 of 6 investors who have invested in Curoverse.

  • Who are Curoverse’s competitors?

    Verogen, Eagle Genomics, AMPED PCR, BC Platforms, and Flatiron are competitors of Curoverse.

  • When was Curoverse acquired?

    Curoverse was acquired on 03-Aug-2017.

  • Who acquired Curoverse?

    Curoverse was acquired by Veritas (Laboratory Services).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process